Cancer Research Institute and Israel Cancer Research Fund Announce Launch of the Immunotherapy Promise Initiative – Newswise (press release)
|
Cancer Research Institute and Israel Cancer Research Fund Announce Launch of the Immunotherapy Promise Initiative
Newswise (press release) Newswise — NEW YORK, August 2, 2017—The Cancer Research Institute (CRI) and Israel Cancer Research Fund (ICRF) today announced the establishment of The Immunotherapy Promise™ fund, a groundbreaking, collaborative campaign bringing … |
|
Cancer Research Institute and Israel Cancer Research Fund Announce Launch of the Immunotherapy Promise Initiative
Newswise (press release) Newswise — NEW YORK, August 2, 2017—The Cancer Research Institute (CRI) and Israel Cancer Research Fund (ICRF) today announced the establishment of The Immunotherapy Promise™ fund, a groundbreaking, collaborative campaign bringing … |
|
Intrexon to Announce Second Quarter and First Half 2017 Financial Results on August 9th
PR Newswire (press release) … delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn. |
|
Intrexon to Announce Second Quarter and First Half 2017 Financial Results on August 9th
PR Newswire (press release) … delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn. |
|
Intrexon to Announce Second Quarter and First Half 2017 Financial Results on August 9th
PR Newswire (press release) … delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn. |
Genetic Literacy Project |
Muscular dystrophy in dogs reversed with gene therapy–are children next?
Genetic Literacy Project Duchenne muscular dystrophy (DMD) is the most common and, sadly, the most severe form of the debilitating genetic disorder. Now researchers have used a new gene therapy technique to restore muscle strength and stabilize the symptoms of the disorder in … |